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Portuguese Abstract 
Ao longo das últimas cinco décadas tem vindo a registar-se um decréscimo da taxa 
de fecundidade humana. Embora existam vários factores que contribuam para tal (por 
exemplo, alterações nos comportamentos sociais), são cada vez mais comuns 
problemas fisiológicos masculinos, como a diminuição da concentração e qualidade 
espermática, que devem ser também considerados importantes. Adicionalmente, 
doenças como hipospádias, criptorquidismo e cancro testicular têm também vindo a 
aumentar de incidência. Devido ao curto período de tempo em que se registam estas 
grandes diferenças, parece pouco provável que haja apenas influência genética a 
actuar. Como em tantos outros problemas recentes, a combinação das variações do 
estilo de vida e da exposição ambiental a moléculas perigosas pode prejudicar o 
desenvolvimento do sistema reprodutor masculino, diminuindo assim a fertilidade. Foi 
proposta uma origem comum na vida fetal para as doenças acima referidas, em que 
uma função deficiente das células somáticas do testículo fetal resultaria numa ruptura 
da organização e desenvolvimento normal, traduzindo-se em problemas reprodutivos 
masculinos. Esta teoria dá pelo nome de Síndrome da Disgénese Testicular (Testicular 
Dysgenesis Syndrome, TDS) e mostra o quão importante é o desenvolvimento fetal das 
estruturas reprodutivas masculinas para uma saúde e função reprodutiva normal 
posterior. Uma das doenças incluídas nesta TDS é o cancro testicular com origem na 
linha germinal (testicular germ cell cancer, TGCC), ao qual é atribuído a maioria das 
mortes relacionadas com problemas de saúde em homens entre os 15 e os 35 anos e 
cuja incidência duplicou nos últimos 40 anos. Durante o desenvolvimento fetal no 
Homem, as células germinais masculinas indiferenciadas mantêm a sua proliferação 
em níveis baixos após a perda de pluripotência e passagem para um estado 
diferenciado. Esta perda de pluripotência parece conter a hipótese de como a TGCC 
surge nos humanos, visto que se o processo for perturbado por factores externos, as 
células podem entrar num estado intermediário em que mantêm a taxa de 
proliferação alta, adquirindo características cancerígenas. Um tipo de molécula 
ambiental ao qual os fetos estão expostos, e que já demonstrou afectar negativamente 
o sistema reprodutor masculino noutras espécies, são os ftalatos, componentes 
industriais cuja exposição em roedores levou ao aparecimento de condições 
semelhantes às da TDS. No entanto, não há informações sobre o seu efeito nos 
humanos. Outros químicos ambientais cujo efeito no desenvolvimento reprodutivo 
pode ser negativo são os anti-inflamatórios não esteróides, tais como o paracetamol e 
a indometacina. Embora o mecanismo exacto ainda não seja conhecido, ambos 
actuam através da inibição da produção ou acção de prostaglandinas, que são lípidos 
libertados pelas células quando ocorre uma inflamação, embora a indometacina seja 
considerada um supressor mais inequívoco do que o paracetamol. A administração de 
paracetamol e outros analgésicos demostrou ter efeitos negativos na saúde 
reprodutiva em roedores. Esta tese centrou-se no estudo do efeito da exposição a 
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químicos ambientais como o ftalato di(n-butyl) (di(n-butyl) phthalate, DBP), 
paracetamol e indometacina no desenvolvimento e diferenciação das células germinais 
fetais, baseando-se em estudos preliminares e não publicados desenvolvidos pelo 
grupo de investigação em que me inseri. Para estudar o efeito do DBP, foram 
recolhidos testículos de fetos humanos (n = 8), com idades compreendidas entre as 14 
e 20 semanas de gestação, para serem xeno-enxertados debaixo da pele dorsal de 
ratos imunodeficientes adultos (machos castrados) em porções pequenas. Sete dias 
após esta operação, os quais permitem o estabelecimento de irrigação sanguínea nos 
enxertos, os hospedeiros recebem doses diárias de controlo, DBP ou MBP (ftalato 
monobutyl, o metabolito activo do DBP) dissolvidos em óleo (500mg/kg/dia), durante 
21 dias. Os hospedeiros ainda são sujeitos a três injecções semanais de gonadotropina 
coriónica humana (20 IU), para replicar as condições normais de gravidez e manter a 
produção de testosterona. Após o período de tratamento, os enxertos são recolhidos, 
fixados, cortados em secções e sujeitos a uma imunofluorescência tripla. No total, 
analisaram-se pelo menos dois enxertos controlos e dois expostos a DBP/MBP para 
cada feto, resultando, no mínimo, em 32 amostras. O protocolo de imunofluorescência 
permite visualizar células germinais com antigénios para OCT3/4 (células germinais 
indiferenciadas), MAGE-A4 (células germinais diferenciadas) e Ki67 (células em 
proliferação). As imagens foram obtidas por microscopia confocal e as células incluídas 
num túbulo seminífero definido, que demonstrassem fluorescência para estes 
antigénios, foram assumidas como pertencendo à linha germinal e contadas 
manualmente. Os valores registados para os enxertos-controlo e expostos a DBP, do 
mesmo feto, foram condensados até se obter um valor médio respectivo. A média dos 
enxertos controlo e dos expostos ao tratamento, de cada um dos fetos, foi utilizada 
então para análise estatística, usando-se um Teste t para amostras emparelhadas 
(significância: P<0.05). Os resultados mostraram que os enxertos expostos ao 
DBP(MBP) registam uma diminuição significativa de mais de 10% na percentagem de 
células germinais positivas para OCT3/4 (indiferenciadas). Por outro lado, a 
percentagem de células germinais positivas para MAGE-A4 (diferenciada) em enxertos 
tratados com DBP(MBP) foi significativamente maior do que os controlos. Porém, a 
proliferação das células germinais indiferenciadas e diferenciadas não registou 
alterações significativas em comparação com as amostras controlo. As células 
germinais reduziram a expressão de OCT3/4 para aumentarem a expressão de MAGE-
A4 quando se diferenciaram, o que coincidiu com a redução, e eventualmente a perda, 
da capacidade proliferativa, demonstrando que o modelo dos xeno-enxertos consegue 
recapitular o desenvolvimento fetal normal das células germinais masculinas nos 
humanos. Estes resultados parecem dever-se a uma apoptose selectiva das células 
indiferenciadas. Se a apoptose fosse geral, a proporção de células germinais 
indiferenciadas e diferenciadas não mudava após o tratamento com o DBP(MBP), o 
que não está de acordo com os resultados obtidos, já que há um aumento de células 
germinais diferenciadas. Devido à falta de dados sobre o efeito do DBP nas gónadas 
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masculinas humanadas, esta hipótese estaria de acordo com dados anteriores de 
estudos in vitro e in vivo, em humanos e roedores respectivamente, em que a 
exposição a DBP reduz o número de células germinais fetais positivas para OCT3/4.  
O segundo projecto desenvolvido e abordado nesta tese foi analisar os efeitos da 
exposição ao paracetamol e indometacina no número de células germinais nos 
testículos fetais de ratos. Fêmeas prenhas de ratos Wistar foram tratadas diariamente 
com paracetamol (350mg/kg/dia), indometacina (1mg/kg/dia ou 0.8mg/kg/dia) ou 
tratamento controlo. O tratamento decorreu entre o dia embrionário (e) 15.5 até ao 
e20.5, sendo os testículos dos descendestes recolhidos ao e21.5. As amostras foram 
fixadas, seccionadas e processadas através de um protocolo imunohistoquímico para o 
antigénio VASA (marcador típico de células germinais). O número de células germinais 
foi obtido por estereologia, que é um método uniforme e sistemático que permite 
analisar a composição celular de um tecido tridimensional, neste caso o testículo, 
através da contagem de núcleos de células germinais em secções bidimensionais desse 
mesmo tecido. Para as amostras fetais e21.5, foram contadas todas as células que 
expressassem VASA e que estivessem contidas num túbulo seminífero definido. A 
comparação entre amostras controlo e as expostas a paracetamol/indometacina foi 
analisada estatisticamente através de uma análise de variância ANOVA (significância: 
p<0.05). Os resultados mostraram uma redução significativa do número de células 
germinais em amostras expostas à indometacina, quando comparadas com as de 
controlo. Embora as gónadas masculinas expostas ao paracetamol não tenham 
apresentado uma diferença significativa, existe uma tendência para a redução do 
número de células germinais. O desenvolvimento normal das células germinais no rato 
passa por perderem totalmente a capacidade proliferativa quando se diferenciam, 
num processo síncrono e uniforme, ao contrário dos humanos. Não se sabe se o 
decréscimo do número de células pode ser atribuído a apoptose devido à falta de 
dados nesta área, mas a indometacina pode induzir um aumento da taxa de 
diferenciação das células germinais fetais, levando à paragem da divisão celular numa 
idade anormalmente precoce.  
Outro ensaio experimental foi desenvolvido para investigar o efeito da exposição 
in utero à indometacina no número de células germinais em testículos de ratos obtidos 
no dia 25 após o nascimento (postnatal day, pnd25). O protocolo para investigar este 
efeito foi em tudo idêntico ao seguido para os testículos e21.5, excepto que não houve 
amostras expostas ao parecetamol e os testículos foram recolhidos após o nascimento 
(embora o período de exposição à indometacina tenha sido de e15.5 a e18.5). Visto 
que a gónada pnd25 já produz espermatozóides, as células germinais foram divididas 
em categorias que correspondem à progressão temporal da espermatogénese: 
espermatogónia, espermatócito I e espermatócito II. O número de células germinais de 
cada categoria, mais o número total de células germinais, foi contado também através 
de esterologia e a comparação estatística entre amostras controlo e tratadas com 
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indometacina foi feita com um Teste t de Student (significância: p<0.05). Os resultados 
mostraram que o número de espermatogónias e o número total de células germinais 
aumentaram significativamente em amostras tratadas com indometacina, enquanto os 
valores para espermatócitos I e II não sofreram alterações significativas. Isto sugere 
que a exposição in utero à indometacina possa induzir apoptose nas células germinais 
e aquelas que resistem conseguem recuperar, embora faseadamente, os seus números 
normais após o nascimento e cessação do período de tratamento. Além disso, ambos 
os ensaios em ratos mostram que, pelo menos em mamíferos, o desenvolvimento fetal 
normal das células germinais, e posterior fertilidade dos indivíduos, é dependente de 
prostaglandinas. 
Este conjunto de estudos mostrou que a exposição fetal a químicos ambientais 
comuns, tais como os ftalatos e inibidores de prostaglandinas, pode afectar o 
desenvolvimento fetal das células germinais nos humanos e no rato, obtendo-se dados 
sobre este tema pela primeira vez. 
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English Abstract 
Lifestyle and environmental exposure to hazardous molecules have been indicated 
as a cause for the decrease in human fertility. An increased incidence of hypospadias, 
cryptorchidism and testicular germ cell cancer has been reported and it has been 
hypothesized that these may form a Testicular Dysgenesis Syndrome (TDS) with a 
common origin in fetal life. Although testicular germ cell cancer (TGCC) occurs in young 
men, it appears that it arises from a failure of fetal germ cells to lose their pluripotency 
and which then transform into carcinoma-in-situ (CIS) cells, which are germ cells (GC) 
with pluripotency and proliferative features that probably lead to TGCC in young 
adulthood. It has been hypothesized that exposure in utero to some environmental 
factors could play a role in disturbing the testicular endocrine function in the fetus, 
possibly leading to TGCC. Di(n-butyl) phthalate (DBP), a common environmental 
chemical, has been shown to affect fetal testis development and endocrine function in 
the rat. Nonsteroidal anti-inflammatory drugs (paracetamol, indomethacin), which are 
believed to work through inhibition of prostaglandins, and other inflammation 
modulators can also affect fetal testis endocrine function in animal models. This study 
therefore aimed to assess the effect of DBP, paracetamol and indomethacin exposure 
on fetal GC development and differentiation. To study DBP effects, second-trimester 
human testis pieces from eight fetuses were xenografted under the backskin of nude 
castrated male mice, which were then treated with vehicle (control) or DBP for 21 
days. Immunofluorescence for OCT3/4 (undifferentiated GC marker), MAGE-A4 
(differentiated GC marker) and Ki67 (proliferative cell marker) was used to analyse GC 
differentiation and proliferation. Exposure to DBP led to a reduction in proportion of 
undifferentiated GC, although proliferative features were maintained, possibly due to 
selective apoptosis. To analyse the effect of indomethacin on GC numbers, e21.5 and 
pnd25 rat testes were evaluated in males exposed in utero to vehicle (control) or 
indomethacin (1mg/kg or 0.8mg/kg) treatment. Immunohistochemistry for VASA (GC 
marker) and stereology was used to assess GC number in e21.5 testes and 
spermatogenic temporal progression in pnd25 testes. Indomethacin exposed e21.5 rat 
testes showed a significant decrease in GC number, which is in agreement with 
preliminary results. Pnd25 rat testes from males exposed in utero to indomethacin 
showed an increase in spermatogonial numbers and total GC number, although the 
numbers for early and pachytene spermatocytes were not different. This shows that 
indomethacin affects germ cell development during the exposure period and that 
there might be a staggered recovery after birth toward normal GC number. Overall, 
these results show for the first time that exposure to common environmental 
chemicals affect human and rat male fetal GC development. 
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Introduction 
Around 1.2 billion years ago, primitive eukaryotes started to reproduce sexually, 
which involves the recombination of parental genomes so that a new genotype is 
created. This allowed the emergence of more dynamic, adaptable life forms in a 
shorter period of time. So, sex and fertility are key factors to determine the future of 
our descendants. Being able to maintain fertility rates above levels of sustained 
population guarantees the existence of a given population as it is and reduces the risk 
of extinction, if no other external factors interact (such as a flood, for example).  
The human species has suffered from variable fertility rates over its history. 
Nowadays, it is accepted that 2.1 is the minimum fertility rate to guarantee the 
sustainability of our species. Until two decades ago, some developing countries could 
reach a fertility rate of 8, and a general decrease has been noticed since. Postponing 
marriage and first births, associated with more women pursuing careers, are usually 
the most accepted reasons for the decrease in fertility rates, which in most Western 
countries do not even reach the replacement level (Skakkebæk et al., 2006; Figure 1).  
 
 
Figure 1. Fertility rates in 1970 (blue columns) and 2002 (red columns). The minimum fertility rate 
of 2.1 is also portrayed (green line) [Reproduced from Skakkebæk et al., 2006]. 
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Although social behaviour can contribute to this change in fertility rates, there are 
physiological changes that should also be considered, such as falling sperm counts 
(Figure 2) and other reduced sperm quality features (less motility and/or abnormal 
shape). Plus, the incidence of hypospadias, cryptorchidism and testicular cancer also 
seem to be increasing (Giwercman et al., 1993; Skakkebæk et al., 2006).  With these 
great differences in a period of 50-70 years, it seems unlikely that only genetics plays 
an important role. Instead, changing lifestyle and environmental exposures to 
hazardous molecules over the years could impair the development of the male 
reproductive tract and result in a decreased fertility (Skakkebæk et al., 2006). 
 
 
Figure 2. Sperm counts declined 
in the last 70 years. Sperm counts 
have changed temporally, declining 
to nearly half in a 70-year period, as 
shown in a review of 101 studies 
[adapted from Swan et al., 2000]. 
 
 
 
 
Testicular Dysgenesis Syndrome 
Although spermatogenesis only starts after puberty and continues for the rest of 
life, the set-up for it is defined during fetal development (Sharpe, 2010). In humans, 
the primordial germ cell lineage can be traced back to the 4.5 day-old blastocyst, 
although it is not fully understood how they develop. It is formed outside of the 
presumptive gonad, which develops from the coelomic epithelium of the urogenital 
ridge, and can be found at the yolk sac, by the fourth week of gestation. The germ cells 
migrate through the gut into the mesoderm and arrive at the genital ridges, where 
their motile properties are lost. The undifferentiated gonad is then composed of germ 
cells and supporting coelomic cells (that give rise to Sertoli cells and Leydig cells) as 
well as other types of interstitial cells and Peritubular Myoid cells (Knobil & Neill, 
1994). During the germ cell migration, the Sertoli cells begin to differentiate and 
aggregate around the germ cells to form spermatogenic cords, a critical process that is 
independent of testicular hormone production (George & Wilson, 1994; Brennan & 
Capel, 2004; Sharpe, 2010). After this, the final step is a new wave of cells from the 
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coelomic epithelium which differentiates into Leydig cells. These migrate into the 
interstitial regions and then begin to produce hormones. 
In mammals, the phenotypic development of external and internal reproductive 
structures in the male is dependent on the hormones the male gonad produces after it 
has formed (Hughes, 2001; Sharpe & Skakkebæk, 2008). In the rat, it has been shown 
that there is an early time window, called the masculinization programming window 
(MPW) in which sufficient androgen action is necessary to set up later masculinization 
of the reproductive tract and guarantee its proper function later in life (Welsh et al., 
2008). Since there is a critical window for hormone action, a risk of disruption if 
external interferences occur should be considered (Sharpe, 2006). For that reason, 
reproductive development disorders in males can be caused by deficient action of 
androgens within the MPW (Sharpe, 2012) and may serve as an explanation for the 
increasing incidence of reproductive disorders in men. It was proposed that male 
disorders such as low sperm counts, cryptorchidism, hypospadias and testicular cancer 
could have a common origin in fetal life, in which testicular dysgenesis results in 
impairment of fetal testis somatic cell function (Skakkebæk et al., 2001, 2006). This is 
named the Testicular Dysgenesis Syndrome (TDS) and it is believed that the 
malformed, or dysgenic, fetal testis will cause faulty Leydig and/or Sertoli cells 
function, increasing the risk of reproductive disorders (Figure 3; Sharpe & Skakkebæk, 
2008). TDS shows how important the normal development of the testis is, along with 
normal hormone action, for normal reproductive function/health in adulthood 
(Sharpe, 2006). 
 
 
Figure 3. Schematic representation of Testicular Dysgenesis Syndrome, where early disruption of 
normal testis development due to genetic or environmental factors can result in clinical problems later 
in life [Image reproduced from Skakkebæk et al., 2001] 
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Testicular Germ Cell Cancer 
The normal development of the testis, as previously shown, can be disturbed by 
environmental factors, leading to impaired germ cell differentiation and resulting in 
testicular cancer. Testicular germ cell cancer (TGCC) accounts for 1-2% of all cancers in 
men, but it is the most common type of cancer in early adulthood, being the biggest 
cause of cancer-related death in 15-35 year-old males (Toppari et al., 1996; Sharpe & 
Skakkebæk, 2003). TGCC incidence has doubled in the past 40 years and, fortunately, 
has a high rate of treatment success (Horwich et al., 2006; Bosl & Motzer, 1997). 
Normal germ cell development during the fetal period is essential to guarantee 
normal functional sperm during adult life. As said previously, highly proliferative and 
undifferentiated primordial germ cells migrate to the genital ridge and are enclosed by 
Sertoli cells, which begin an ongoing differentiation, during fetal life. The primordial 
germ cells are then called gonocytes and begin to differentiate into spermatogonia, 
the initial cell type of the spermatogenesis process, during the 2nd and 3rd trimester of 
pregnancy. The remaining gonocytes disappear throughout the first year of postnatal 
life (Skakkebæk et al., 1998) and normal spermatogenesis can occur in adulthood 
(Sharpe, 2010). During fetal rat development, primordial germ cells only proliferate 
during their pluripotency phase, typified by the expression of pluripotency markers 
shared with embryonic stem cells, such as octamer-binding transcription factor 3/4 
(OCT3/4). The loss of this marker coincides with the quiescence phase of germ cells. In 
the human, germ cells have a similar behaviour, where they also lose OCT3/4 
expression (Cools et al., 2006), though differentiated germ cells (OCT3/4 negative germ 
cells) still proliferate at a much lower rate (Mitchell et al., 2010). When this happens, 
they switch on expression of VASA and MAGE-A4 which mark the transition to a 
differentiated, and still slightly proliferative, state (Rajpert-De Meyts, 2006).  
The loss of pluripotency of primordial germ cells holds the hypothesis of how 
TGCC begins in humans. If the primordial germ cells fail to lose pluripotency (Horwich 
et al., 2006; Western et al., 2010) or there is a delay or block in their development 
(Cools et al., 2006), they can enter an arrested state where they tend to be more 
proliferative than normal differentiated germ cells. This is believed to lead to the 
development of carcinoma-in-situ (CIS) cells (Rajpert-de Meyts & Hoei-Hansen, 2007; 
Sharpe, 2010; Western et al., 2010), which are germ cells with pluripotency and 
proliferative features that can spread along a seminiferous tubule throughout 
childhood, probably leading to TGCC in young adulthood (Sharpe, 2010). Support for 
this theory has been given by Jørgensen et al. (1995), who showed that CIS cells 
express a similar profile of markers as do gonocytes and primordial germ cells, having 
stem cell-like features such as pluripotency that are down-regulated when they 
differentiate into spermatogonia (Rajpert-de Meyts & Hoei-Hansen, 2007) (Figure 4). It 
has been hypothesized that impaired function of supporting cells (Sertoli, Leydig and 
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Peritubular Myoid cells) alters normal germ cell differentiation, as conditions of partial 
androgen insensitivity are associated with substantially increased risk of TGCC 
(Skakkebæk et al. 1998; Eddy, 2002; Sonne et al., 2009; Wohlfahrt-Veje et al., 2009). 
Because these events happen during pregnancy, it suggests that there can be 
environmental or lifestyle effects on the foetus via the mother that are likely to be 
irreversible (Sharpe, 2010). 
 
Figure 4. Current hypothesis of how CIS cells are thought to arise, because of a failure of primordial 
germ cell/gonocyte differentiation, which would normally result in the loss of pluripotency gene 
expression. The resulting CIS cells stay dormant until puberty and then develop into a tumour in young 
adulthood. ESC, embryonic stem cells; PGC, primordial germ cells; CIS, carcinoma in situ cells. [Image 
reproduced and adapted from Rajpert-De Meyts, 2006]. 
 
 
When it comes to environmental chemicals that might affect testis development, 
they are considered a growing threat to health due to their wide use in developed 
countries. Occupational exposure and pollutants have been related to negative effects 
on sperm counts and spermatogenesis in the human (Sharpe, 2010). Additionally, 
studies in animal models showed that environmental chemical exposure, either to 
individual chemicals (although in considerably higher doses than expected to affect 
humans) or to a combinations of several chemicals, due to lifestyle choices, can induce 
disorders similar to those of TDS in offspring (Gray et al., 2001; Sharpe, 2012). This 
study focuses on how environmental chemicals, namely phthalates and indomethacin, 
have an impact on germ cell development in the human and rat fetal testis. 
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Phthalates 
Phthalates are the most abundant man-made environmental chemicals, used 
extensively in industrial applications, such as solvents, plasticizers, floorings, medical 
devices, personal-care and cosmetic products and others. The routes of intake include 
ingestion, inhalation and dermal contact (Diamanti-Kandarakis et al., 2009). Phthalate 
exposure in fetal life has been shown to be associated with reduced anogenital 
distance, cryptorchidism, hypospadias and decreased fetal testis testosterone 
synthesis in rats (Fisher, 2004; Diamanti-Kandarakis et al., 2009; Drake et al., 2009). It 
is important to note that most experimental studies have used the rat as a model and 
have used phthalate exposure levels far higher than occur in humans and, 
consequently, extrapolation to the human situation should be done carefully. There 
are many different phthalates and not all of them cause effects on reproductive 
development in rats (Gray et al., 2001). The most common phthalates that humans are 
exposed to are diethylhexyl phthalate (DEHP) and di(n-butyl) phathalate (DBP), both of 
which have been shown to have similar effects on the fetal rat testis (Howdeshell et 
al., 2008). Both of these phthalates are metabolised to their monoesters, mono-(2-
ethylhexyl) phthalate (MEHP) and monobutyl phthalate (MBP) respectively, which act 
as active toxicants in the testis (Fisher, 2004).  
Phthalates have been used in different animal models to show how they can 
disrupt the normal development of the reproductive tract. Higuchi et al. (2003) 
showed that DBP caused reproductive toxicity in rabbits, with a more pronounced 
effect if the exposure was in utero. Impairment of spermatogenesis and long-term 
maldevelopment of the male reproductive structures after in utero exposure to DBP in 
rats was documented by Barlow & Foster (2003). Lee & Veeramachaneni (2005) used 
low concentrations of DBP during the sexual differentiation period on Xenopus laevis 
frogs, which revealed a variety of testicular lesions that persisted into adulthood, long 
after the exposure to DBP had ceased. It was proposed that dermal contact, due to 
living in an aquatic environment, could have enhanced the DBP effects, which could 
mimic the exposure of mammals in amniotic fluid. Other studies in rodents concluded 
that fetal exposure to DBP impaired normal seminiferous cord development, with an 
increased incidence of multinucleated gonocytes (Ferrara et al., 2006; Gaido et al., 
2007; Scott et al., 2007). In utero exposure to DBP also has effects on germ cell 
differentiation in rats, causing a slight prolongation of pluripotency marker expression 
and other effects indicative of “delayed” normal development (Ferrara et al., 2006; 
Jobling et al., 2011). This can be compared with the idea that CIS cells arise from 
arrested gonocytes, maintaining pluripotency gene expression and behaviour that 
enhances their potential to become malignant.  
Although phthalates act in an anti-androgenic way by suppressing fetal Leydig cell 
androgen production, their effects on germ cells are independent of androgen action 
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(Lehraiki et al., 2009) and therefore probably involve alteration of Sertoli cell function 
(Li et al., 2000; Jobling et al., 2011). Therefore, because embryonic development has 
conserved pathways, altered germ cell development and induction of TDS-like 
disorders after phthalate exposure in rats points to potential effects also in humans 
(Fisher, 2004; Carruthers & Foster, 2005; Kleymenova et al., 2005; Gaido et al., 2007).  
Indeed, Lambrot et al. (2009) have reported an effect in vitro of phthalates on germ 
cell number in the fetal human testis. In addition, Fisher (2003) concluded, after 
analysing the effects of DBP exposure in utero on rat testis development, that the 
results were remarkably similar to human TDS disorders and, since there is no animal 
model for human TDS currently, studying fetal rat development could provide a model 
system to understand the underlying mechanisms of human TDS. However, Mitchell et 
al. (2012) reported that human fetal testes, which were xenografted subcutaneously 
under the dorsal skin of male nude mice, appear to have unaffected steroidogenesis 
after the host mice are treated with DBP. This is in accordance with previous in vitro 
data and marmoset studies (Lambrot et al., 2009; McKinnell et al., 2009). 
However, we still do not know if the level of phthalate exposure in humans is 
sufficient to impair testis development and if in utero exposure can affect germ cells 
during fetal development. 
 
 
Paracetamol effect through Prostaglandins 
Paracetamol is generally used during pregnancy, which is believed to be safe at 
therapeutic doses, along with other over-the-counter painkillers (Werler et al., 2005), 
in response to inflammatory processes such as pain. However, the use of analgesics 
during pregnancy has been associated with increased risk of asthma (Rebordosa et al., 
2008) and cryptorchidism (Kristensen et al., 2011a) in children. Paracetamol is believed 
to work through the inhibition of prostaglandins, although the exact mechanism of 
action is still unknown. Prostaglandins are short-lived lipids that are synthesized by 
many cells (excluding mature erythrocytes) and are released as a response to cell 
membrane traumas such as inflammation. Nonsteroidal anti-inflammatory drugs (e.g., 
paracetamol, indomethacin and aspirin) seem to act through the inhibition of 
prostaglandin release in response to inflammatory signals, thus relieving pain 
(McDonald-Gibson & Collier, 1979; Vane & Botting, 1987). Prostaglandins have 
arachidonic acid as a precursor, the production of which is catalyzed by 
cyclooxygenase (COX), which has two isoforms: COX-1 and COX-2.  COX has three 
different folding units, an epidermal growth factor-like domain, a membrane-binding 
domain and an enzymatic domain. The COX active site presents itself as a channel, 
with a hydrophobic profile. COX-2 can bind larger molecules than COX-1, due to its 
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bigger active site (Vane & Botting, 1998). Paracetamol is believed to compete with 
arachidonic acid for the COX binding site, with some preference for COX-2, hence 
inhibiting the formation of prostaglandins and reducing the inflammatory response 
(FitzGerald, 2003; Graham & Scott, 2003) (Figure 5). Indomethacin works by inhibiting 
directly and non-selectively the catalytic action of COX (although it is more active 
against COX-1), binding to the upper portion of the active site, preventing its substrate, 
arachidonic acid, from entering the active site and preventing the formation of 
prostaglandins (Mitchell et al., 1994). It is considered to be a more unequivocal 
suppressor of prostaglandins that paracetamol. 
 
 
 
Figure 5. Formation of prostaglandins 
(PGs) after arachidonic acid (AA) is catalysed 
by cyclooxygenase (COX). It is believed that 
nonsteroidal anti-inflammatory drugs 
(NSAID), like paracetamol and indomethacin, 
inhibit PGs production by competing with AA 
for the COX binding site. 
 
 
 
Paracetamol exposure in pregnant rats has been shown to cause mild inhibition of 
testosterone and prostaglandin D2 production (Kristensen et al., 2011a). Older studies have 
suggested a link between prenatal exposure to mild analgesics and reduced masculinisation in 
animals (Gupta & Goldman 1986; Gupta, 1989). This is further supported by the anti-
androgenic effects of paracetamol discovered in rat models leading to a small reduction in 
anogenital distance (Kristensen et al., 2011a). As prostaglandin receptors are also expressed in 
Sertoli cells, contributing to cell differentiation and expression of male specific genes in mice 
(Wilhelm et al., 2005), it is possible that disruption of this system could be caused by exposure 
to paracetamol or other painkillers during pregnancy, such as indomethacin. 
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Aims 
This study is focused on germ cell development during fetal life and on the impact 
of chemical/medicinal drug exposure, both in the human and in the rat. Therefore, it is 
my aim to: (1) identify whether DBP exposure affects male human fetal germ cell 
development and differentiation in a xenograft model; and (2) to analyze the effect of 
paracetamol and indomethacin on male rat germ cell number. Both studies have been 
prompted due to preliminary unpublished data developed by Lenka Hrabalkova (2011). 
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Protocols and Procedures 
 
Human studies 
Tissue collection and xenografting procedure 
Second-trimester (14 – 20 weeks, n = 8) human fetal testes were obtained 
following termination of pregnancy, which were unrelated to fetal abnormalities. 
Women gave consent in accordance with British national guidelines and ethical 
approval was obtained from the Lothian Research Ethics Committee, as reported by 
Mitchell et al. (2010). Small portions of each testis were fixed as a pre-graft control. 
The rest were handled for xenografting, by being placed in ice cold media (containing 
Liebowitz L-15 with glutamine, 10% fetal bovine serum, 1% penicillin/streptomycin and 
1% non-essential amino acids; all Sigma, Poole, UK). Fetal testis specimens were also 
obtained at gestational ages equivalent to the end of the grafting period and fixed as 
age-matched controls. Xenografting followed the protocol described in Mitchell et al. 
(2010; Figure 6), which was shown to recapitulate normal fetal testis growth for 6 
weeks or more after grafting. After xenografting 4 – 6 human fetal testis pieces under 
the back skin of castrate adult male nude mice, and allowing 7 days for grafts to 
establish a blood supply, the host mice were treated daily by oral gavage with 
500mg/kg/day of DBP, MBP or vehicle (control) for a period of 21 days. Additionally, 
they received injections of 20 IU of hCG three times a week in order to replicate 
normal pregnancy conditions and to maintain testosterone production, as described in 
Mitchell et al. (2010). Overall, 32 samples were analyzed (from each of eight foetuses, 
there were at least 2 vehicle and 2 DBP/MBP-exposed xenografts). 
 
 
 
Figure 6. Image representative of the 
xenografting procedure. Small pieces of donor 
human testis tissues are inserted 
subcutaneously under the dorsal skin of 
castrated male CD1 nude mice. After the post-
surgery, mice are exposed to the treatment 
explained in the text. Grafts were retrieved 
and weighted after 6 weeks. 
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Tissue fixation, microtoming and mounting 
Pre-grafted, xenografted and age-matched controls and xenografted treated 
tissues were fixed in Bouin’s fixative for two hours, transferred to 70% ethanol and 
then processed into paraffin blocks using standard procedures. 
For microtoming, all paraffin blocks were chilled by being placed on a metal plate 
on top of a container full of ice. Blocks were trimmed and cut into 5µm sections on a 
manual rotative microtome (Leica RM 2135; Leica Microsystems), forming wax ribbons. 
These were transferred to a 40°C  waterbath (Tissue Flotation Bath; ThermoScientific) 
and then placed on electrostatically positive charged slides (Surgipath X-Tra Adhesive 
Precleaned Microslides; Leica Microsystems), which were left overnight at 57°C in a 
fanned convection incubator (Carbolite, UK).  
 
 
 
Triple Immunofluorescence for OCT3/4, MAGE-A4 and Ki67 
Markers for undifferentiated germ cells (octamer binding transcription factor 3/4; 
OCT3/4), differentiated germ cells (MAGE-A4) and proliferating cells (Ki67) were used 
to investigate germ cell expression patterns, as per previous reports (Gaskell et al., 
2004; Mitchell et al., 2008; Mitchell et al., 2010). Information regarding antibodies, 
dilutions, sera and fluorescence used are shown in Table I.  
Sections were subjected to a dewax and rehydration process, by immersing in 
xylene (5 min), then in graded alcohols (100%, 90% and 70%, 20sec each) and finally 
washed in tap water. Heat-induced antigen retrieval was performed in 0,01M citrate 
buffer (citrate is diluted in deionized water, 1:10; pH6; Sigma) and, after being left to 
cool in tap water, the slides were subjected to an endogenous peroxidase block with 
3% (v/v) H2O2 (VWR Prolabo) in methanol (Fisher Scientific, UK) for 30min.  Two 5min 
TBS (Tris-buffered saline; 0,05M Tris and 0,85% NaCl; pH 7,6) washes were performed, 
and they were repeated between each step of this immunofluorescence protocol. 
Slides were then incubated for 30min in normal chicken serum diluted 1:5 with TBS 
containing 5% (w/v) bovine serum albumin (NChS/TBS/BSA). Slides were then 
incubated overnight (at 4°C) with primary antibody OCT3/4. 
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Table I. Antibodies, dilutions, sera and fluorescence details for the triple immunofluorescence 
procedure on human fetal testis. 
a
 Gift Dr Guilio Spagnoli; 
b
 Chicken anti-Goat Peroxidase; 
c
 Chicken anti-
Mouse Peroxidase; 
d
 Normal Chicken Serum; 
e
 Tyramide-Cyanine3; 
f
 Tyramide-Cyanine5; 
g
 Tyramide-
Fluorescein. All secondary antibodies were diluted 1:200 in NChS/TBS/BSA. 
Primary 
Antibody 
Source 
Species 
Raised 
Dilution 
Secondary 
Antibody 
Normal 
Serum/TBS/BSA 
Fluorescence 
OCT3/4 
Santa 
Cruz 
Goat 1:100 ChaGPb NChSd 
Tyramide-
Cy3e 
MAGE-
A4 
Gifta Mouse 1:100 ChaMPc NChS 
Tyramide-
Cy5f 
Ki67 Dako Mouse 1:200 ChaMP NChS Tyramide-Flg 
 
 
 
On the next day, slides were incubated with secondary antibody ChaGP for 30min, 
according to Table I. Then, Tyramide-Cy3 (Tyramide Signal AmplificationTM – Cyanine3; 
PerkinElmer), which is red detection, was applied for 10min to all slides following the 
manufacturer’s instructions. Slides, which were kept in the dark from this point 
onwards, were blocked with 3% (v/v) H2O2 in TBST (TBS plus 0.05% Tween; Tween®20, 
Sigma). Normal chicken serum block step was repeated and MAGE-A4 primary 
antibody was applied to all slides, which were left to incubate overnight (at 4°C). 
The next day, slides were submitted to secondary antibody ChaMP for 30 min (see 
Table I). They were then submitted to Tyramide-Cy5 (blue detection; Tyramide Signal 
AmplificationTM – Cyanine5; PerkinElmer) for 10 min. After this, slides were 
microwaved in citrate buffer (with same dilution as for the heat-induced antigen 
retrieval step) on full power for 2.5min and then left to stand for 20min. Normal 
chicken serum block was repeated once again and slides were then incubated 
overnight (at 4°C)  with the last primary antibody (Ki67). Afterward, secondary 
antibody ChaMP was applied the next day for 30 min. Slides were then incubated with 
Tyramide-Fl (green detection; Tyramide Signal AmplificationTM – Cyanine5; 
PerkinElmer) for 10min. To stain all cell nuclei, all slides were counterstained for 10 
min with DAPI (4',6-diamidino-2-phenylindole; Sigma), which is diluted 1:1000 in TBS. 
Permafluor Aqueous Mounting Medium (ThermoScientific) was used to mount the 
slides. 
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Fluorescence capture and germ cell quantification 
Fluorescence was captured using a Zeiss LSM 710 Axio Observer Z1 confocal laser 
microscope (Carl Zeiss Ltd.), which scans individual tiles from the full section, without 
overlap. These tiles were saved and used to count stained germ cells according to 
Table II. Since Ki67 is not specific for germ cells, it was not considered unless it co-
localized with either OCT3/4 and/or MAGE-A4 staining. Overall, there were six 
different staining classes (Table II): 
 
Table II. List of all the staining combinations counted after scanning fetal human testis 
immunofluorescently for three different antibodies (OCT3/4, MAGE-A4, Ki67).  Ki67 is a proliferation 
marker and it is not germ cell specific, so it was only recorded when in combination with either of the 
other two germ cell specific markers. 
Germ cell antibodies 
Detected germ 
cell fluorescence 
Real 
Example 
Stained cell compartment 
OCT3/4 Red 
 
Nucleus 
MAGE-A4 Blue 
 
Cytoplasm 
MAGE-A4 + OCT3/4 Red + Blue 
 
Nucleus and cytoplasm 
Ki67 + OCT3/4 Green + Red 
 
Only nucleus or cytoplasm 
and nucleus 
Ki67 + MAGE-A4 Green + Blue 
 
Nucleus and cytoplasm 
Ki67 + MAGE-A4 
+ OCT3/4 
Green + Blue + Red 
 
Nucleous and cytoplasm 
 
 
All of these combinations were counted manually with a “laboratory counter” 
(Clay Adams Laboratory Counter). Then, the percentage of OCT3/4 positive (OCT3/4+) 
and MAGE-A4 positive (MAGE-A4+) cells were calculated, in order to know the fraction 
of proliferating cells (cells stained for OCT3/4, or MAGE-A4, together with Ki67). Once 
the information for each age was gathered, average means were calculated to be 
statistically analysed. For the grafts numbered FT2546/7 (17w/19w), two foetuses 
were grafted but they were indistinguishable, so they were handled as an 18w foetus. 
MBP was used in some cases and is considered as being equivalent to DBP.  
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Rat Studies 
Tissue collection, fixation, microtoming and mounting 
Wistar rats were housed under standard conditions according to UK home office 
guidelines and had free access to fresh tap water and soy-free food. Time-mated 
female rats were treated daily with paracetamol (350mg/kg/day) by oral gavage or 
with indomethacin (1mg/kg/dia or 0.8mg/kg/dia) dissolved in corn oil by subcutaneous 
injection. Control females were treated with corn oil by oral gavage or subcutaneous 
injection. Table III shows the gestational ages when the treatments were performed: 
 
Table III. Treatment details during rat fetal development regarding the testis collection day (e, 
embryonic day; pnd, postnatal day). 
  
Treatment Period 
  
Control Paracetamol Indomethacin 
Testis 
Collection 
Day 
e21.5 
e15.5 – e18.5 
(n = 12, from 8 litters) 
e15.5 – e20.5 
(n = 9, from 5 litters) 
e15.5 – e18.5 
(n = 14, from at least 6 litters) 
pnd25 
e15.5 – e18.5 
(n = 4, from 4 litters) 
– 
e15.5 – e18.5 
(n = 4, from at least 3 litters) 
 
 
Tissue collection and fixation was performed in accordance with Dean et al., 2012. 
To generate slides, the microtoming and mounting technique used previously for 
human tissue was replicated for rat tissue, with no modifications. 
 
 
 
Immunohistochemistry for VASA 
Antibody dilutions and serum used are listed in Table IV. Tissue dewax and 
rehydration, antigen retrieval, methanol/peroxide block and TBS washes were all done 
as described above for triple immunofluorescence in human testis, with no 
modifications. For normal serum block, normal goat serum (NGS/TBS/BSA; dilution 
performed as explained for NChS/TBS/BSA) was used to incubate slides for 30min. 
Then, primary antibody VASA, a germ cell specific marker (Rajpert-De Meyts, 2006), 
was added to slides and left overnight (at 4°C).  
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Table IV. Antibody, dilution and serum details for the immunohistochemistry procedure on rat 
testis. 
a
Goat anti-Rabbit Biotinylated (diluted 1:500 in NGS); 
b
 Normal Goat Serum. 
Primary 
Antibody 
Source 
Species 
Raised 
Dilution 
Secondary 
Antibody 
Normal 
Serum/TBS/BSA 
VASA Abcam Rabbit 1:20 GaRBa NGSb 
 
 
The next day, after two 5min TBS washes, slides were incubated for 30 min with 
secondary antibody, diluted 1:500 in NGS. Rat testis sections were then incubated with 
Streptavidin labelled horseradish peroxidase enzyme conjugate (Streptavidin-HRP; 
Vector laboratories), diluted 1:1000 in TBS, for 30min. Staining was then developed 
using 3,3-diaminobenzidine tetrahydrochloride (DAB substrate kit for peroxidise; 
Vector laboratories) for up to 10min. This reaction was stopped by placing the slides in 
tap water and there was no need to perform any other TBS wash. The slides were 
counterstained with haematoxylin and washed in tap water. They were drained as 
much as possible and submitted to a dehydration process, by being exposed to graded 
alcohols (70%, 80%, 90%, 100%; 20sec each). Then, the slides were placed in xylene 
(5min) and mounted using a xylene-based mountant, Pertex (Cellpath plc). 
 
 
 
Staining detection and germ cell quantification 
All images were captured using a JVC camera attached to an Olympus AX70 
microscope and all countings were performed using Axiovision Rel. 4.8. software.  
Germ cell quantification followed a stereology method, which is a technique that 
extracts quantitative information, such as the cellular composition, of a three-
dimensional tissue from measurements made on two-dimensional planar sections of 
that tissue. The principle relies on identifying how many cell nuclei are present, as 
most nuclei are essentially spheroidal and thus the chances of detecting a cell nucleus 
is directly proportional to the number of such nuclei and their size. Stereology aims to 
estimate the number of cell nuclei and then, after measuring average nuclear size, to 
determine the absolute numbers of that cell in a given 2-dimensional area of tissue. 
The number of such cell per whole organ/tissue specimen can then be determined if 
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the weight or volume of the specimen is known. Stereology does not just count all cell 
nuclei, it does this in an “unbiased” manner, either by random selection of areas to be 
counted or by systematic selection. On fields of view, a grid with 25 x 19 points is then 
superimposed and the percentage of points that fall over the nucleus in question is 
counted. This enabled the determination of the total germ cell nuclear volume per 
testis. After this, germ cell mean nuclear volume was measured following the same 
stereology principles (by measuring the volume of germ cell nucleus from a random 
selection of two-dimensional fields, which is assumed to be representative of the 
three-dimensional tissue, and then by calculating the mean volume of all measured 
germ cell nuclei) (Figure 7).  
 
 
 
          
 
  
Figure 7. Series of images of the stereology 
method used to estimate germ cell number of 
the fetal rat testis from a two-dimensional 
section. (A) There is a random selection of at 
least 50 fields of view and (B) a grid with 25 x 
19 points is superimposed on each field, 
allowing the number of points that fall over a 
nucleus to be counted (black stars). After this, 
(C) the same method is performed to measure 
the mean germ cell nuclear volume, by 
creating angled straight lines from the centre 
of the nucleus and marking its borders on 
those lines (black arrow). (A) is shown on 2x 
objective; (B, C) are shown on 63x objective. 
 
 
 
B 
C 
A 
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The percentage of points that fall over a germ cell nucleus and the germ cell mean 
nuclear volume are used to calculate the number of germ cells (in millions), through 
the formulas shown in Figure 8 below. 
 
          
                                                  
                                
      
 
                           
                           
   
 
 
                       
                  
                    
       
 
Figure 8. Formulas used to calculate the germ cell number (millions), which was then used in 
statistical analysis. GC, germ cell. 
 
For each e21.5 section, between 50 – 100 random fields were selected at 2x 
objective and all measurements were then performed using a 63x objective. All cells 
stained with VASA within a clearly defined tubule were assumed to be germ cells and 
counted as such.   
For pnd25 comparisons, each section had between 25 – 65 random fields selected 
at 2x objective and all measurements were then performed using a 63x objective. 
Germ cells stained with VASA within a clearly defined tubule were separated into three 
classes, according to the description in Table V. These criteria follow the temporal 
appearance of different germ cell types with the progression of spermatogenesis. 
  
Table V. All classes of VASA-stained germ cells counted for pnd25 samples, with morphological 
description. 
Germ Cell Class Description 
Spermatogonia  With flat oval nucleus; near or touching the basal 
membrane 
Early Spermatocyte Round nucleus; close to, but not necessarily 
touching, the basal membrane 
Pachytene Spermatocyte Big cells with possibly bigger nuclei, darker VASA 
staining and always inside the early spermatocyte 
layer, towards the centre of the tubule 
18 
 
Statistical analysis 
All statistical analyses were carried out using GraphPad Prism version 5 software 
and statistical significance was set at P<0.05. To analyse the human samples, a paired 
t-test was used after calculating the average means for vehicle-exposed (control) and 
DBP-exposed samples from the same fetus. This was performed as shown below 
(Figure 9).  
 
Fetus A         
Vehicle         
Nude mouse A 
 Xenograft 1 — GC values  
Mean 
Value 
 
Used for 
statistical 
analysis 
 Xenograft 2 — GC values   
Nude mouse B 
 Xenograft 1 — GC values   
 Xenograft 2 — GC values   
Nude mouse C 
 Xenograft 1 — GC values   
 Xenograft 2 — GC values   
        
DBP        
Nude mouse D 
 Xenograft 1 — GC values  
Mean 
Value 
 
 Xenograft 2 — GC values   
Nude mouse E 
 Xenograft 1 — GC values   
 Xenograft 2 — GC values   
Nude mouse F 
 Xenograft 1 — GC values   
 Xenograft 2 — GC values   
 
Figure 9. Representation of the statistical analysis of all eight human fetuses. The xenografted 
pieces were collected from their nude mice hosts and, after counting all types of stained germ cells from 
that fetus, a mean value was found for: OCT3/4
+
 germ cells; MAGE-A4
+
 germ cells; OCT3/4
+
/Ki67
+
 germ 
cells; and MAGE-A4
+
/Ki67
+
 germ cells. The control mean value and the DBP-treated mean value for each 
foetus were then used for statistical analysis. DBP, Di(n-butyl) phathalate; GC, germ cell. 
 
For e21.5 rat testis, comparison between control samples with paracetamol and 
indomethacin-treated samples was done by one-way analysis of variance (ANOVA). To 
compare pnd25 controls with indomethacin-treated samples, a Student’s unpaired t-
test was performed for each type of germ cell and for the total number of germ cells. 
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Results 
 
 
The effect of DBP on germ cell differentiation and proliferation in 
human fetal testis xenografts  
The first step of data analysis was to record the values counted for all six types of 
stained germ cells, for all of the human fetal testis xenografts for each fetus (Figure 10, 
red box).  
 
 
 
Fetus A         
Vehicle         
Nude mouse A 
 
Xenograft 1 — GC values 
 
Mean 
Value 
 
Used for 
statistical 
analysis 
 Xenograft 2 — GC values 
  
Nude mouse B 
 
Xenograft 1 — GC values   
 Xenograft 2 — GC values   
Nude mouse C 
 
Xenograft 1 — GC values   
 Xenograft 2 — GC values   
        
DBP        
Nude mouse D 
 
Xenograft 1 — GC values 
 
Mean 
Value 
 
 Xenograft 2 — GC values   
Nude mouse E 
 
Xenograft 1 — GC values   
 Xenograft 2 — GC values   
Nude mouse F 
 
Xenograft 1 — GC values   
 Xenograft 2 — GC values   
 
Figure 10. Schematic representation of the first, second and third step of data analysis for the 
human studies. The first step (red box) consisted of recording the numbers of all six stained germ cell 
categories counted for all fetuses. The second step (blue box) simply involved calculation of the mean 
values/fetus for vehicle (control) and DBP-exposed samples for the six GC staining categories. The mean 
values were then used for statistical analysis (green box). GC, germ cell. 
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An example of germ cell values recorded for an age-matched control section from 
a 16 week fetus is shown in Table VI. The same is performed for age-matched controls, 
pre-grafted controls, vehicle controls and DBP(MBP) exposed xenografts for all 
foetuses (Table VII). A minimum of 100 germ cells were counted for each human fetal 
testis xenograft. If that number was not reached with one section, an 
immunofluorescence protocol was performed on up to 3 sections from the same 
tissue, until that number was reached, by adding the new values to those previously 
counted. 
 
 
Table VI. Germ cell information gathered from a section of an age-matched control of a 16 week 
foetus (block 2004-1391, section number 17). Germ cell stain types were counted and absolute values 
were recorded. The total number of germ cells stained for OCT3/4 (and MAGE-A4), whether they were 
co-stained with Ki67 or not, was calculated. However, because most sections had very low values for 
OCT3/4
+
 / MAGE-A4
+
 co-stain and triple stain, these values were disregarded when the total OCT3/4
+
 
and MAGE-A4
+
 values were determined. Then, the percentage OCT3/4
+
 germ cells and MAGE-A4
+
 germ 
cells in the section were calculated. The percentage of proliferative cells found in the OCT3/4
+
 and 
MAGE-A4
+
 pool was also recorded. The highlighted values (red discontinuous line) were the ones used 
for the next phase of data analysis. MCTRL, age-matched control; %, percentage; GC, germ cells. 
Section 2004-1391.17 MCTRL 
Germ cell stain types 
Absolute 
values 
Percentage (%) 
How (%) 
is called 
How (%) 
was calculated 
OCT3/4+ 214  
% proliferative 
OCT3/4
+
 GC 
        i 7
 otal       
   00 
          OCT3/4+/ Ki67+ 90 
29,61 
          Total OCT3/4+ 304 72,04 % OCT3/4
+
 GC 
 otal       
 otal   
   00 
MAGE-A4+ 112  
% proliferative 
MAGE-A4
+
 GC 
 A   A   i 7
 otal A   A 
   00 
        MAGE-A4+ / Ki67+ 5 4,27 
          Total MAGE-A4+ 117 27,73 % MAGE-A4
+
 GC 
 otal A   A 
 otal   
   00 
OCT3/4+ / MAGE-A4+ 0    
Triple 1    
Total GC 422    
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Table VII. Germ cell values from all treatments and controls for a 16 weeks foetus. The values 
highlighted in Table V are shown on the first line of this Table, also highlighted (red discontinuous line). 
The rest of the table is completed by following the same procedure for all human fetal testis xenograft 
sections for this 16 week fetus. MCTRL, age-matched control; CTRL, pre-graft control; VEH, vehicle 
control; DBP (MBP), DBP or MBP exposed samples; GC, germ cell. 
16 week 
fetus 
Block % OCT3/4+ GC 
% proliferative 
OCT3/4+ GC 
% MAGE-A4+ 
GC 
% proliferative 
MAGE-A4+ GC 
MCTRL 2004-1391 72,04 29,61 27,73 4,27 
CTRL 2010-3588 7,99 8,00 92,01 0,00 
VEH 2010-3594 A 8,82 55,56 91,18 0,00 
2010-3594 C 4,55 83,33 95,45 0,00 
2010-3595 A 9,92 58,33 90,08 0,00 
2010-3595 C 2,03 100,00 97,97 0,00 
DBP 
(MBP) 
2010-3598 A 4,13 80,00 95,87 0,00 
2010-3598 C 3,13 85,71 96,88 0,46 
2010-3599 A 1,35 100,00 97,97 0,00 
2010-3599 C 5,45 35,71 94,16 2,48 
 
 
The second step was to find the mean values for control and DBP(MBP) exposed 
human fetal testis xenografts (Figure 10, blue box). For each fetus, a mean percentage 
was calculated for control and DBP (MBP) exposed human fetal testis xenografts (Table 
VIII). All means were gathered into Table IX. 
 
 
Table VIII. How average means were calculated for control and DBP treated groups following on 
from the example given for a 16 week fetus in Table VII. The mean percentage of control OCT3/4
+
 germ 
cells was found by calculating the average mean of age-matched controls (MCTRL), pre-graft controls 
(CTRL) and vehicle controls (VEH) (red box). The mean percentage of DBP(MBP) treated OCT3/4
+
 germ 
cells was found by calculating the average mean of DBP and MBP exposed xenografts (green box). The 
same technique was done for % proliferative OCT3/4
+
 germ cells; % MAGE-A4+ germ cells; % 
proliferative MAGE-A4+ germ cells. GC, germ cell. 
16 week 
fetus 
Block % OCT3/4
+
 GC 
% proliferative 
OCT3/4
+
 GC 
% MAGE-A4
+
 
GC 
% proliferative 
MAGE-A4
+
 GC 
MCTRL 2004-1391 72,04 29,61 27,73 4,27 
CTRL 2010-3588 7,99 8,00 92,01 0,00 
VEH 2010-3594 A 8,82 55,56 91,18 0,00 
2010-3594 C 4,55 83,33 95,45 0,00 
2010-3595 A 9,92 58,33 90,08 0,00 
2010-3595 C 2,03 100,00 97,97 0,00 
DBP 
(MBP) 
2010-3598 A 4,13 80,00 95,87 0,00 
2010-3598 C 3,13 85,71 96,88 0,46 
2010-3599 A 1,35 100,00 97,97 0,00 
2010-3599 C 5,45 35,71 94,16 2,48 
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Table IX. All mean values for all four control and DBP exposed groups (% OCT3/4
+
 germ cell; % 
MAGE-A4+ germ cells; % proliferative OCT3/4
+
 germ cells; % proliferative MAGE-A4+ germ cells). The 
control mean average (red box) and the DBP (MBP) treated mean average (green box) for the values 
highlighted in Table VII are shown for a 16 week fetus. These values were used to perform four paired t-
tests, each one corresponding to one of the analysed groups. w, week; GC, germ cell. 
   Analysed 
Groups 
 
 
      Ages       
% OCT3/4+ GC % MAGE-A4+ GC 
% proliferative 
OCT3/4+ GC 
% proliferative 
MAGE-A4+ GC 
Control 
DBP 
(MBP) 
Control 
DBP 
(MBP) 
Control 
DBP 
(MBP) 
Control 
DBP 
(MBP) 
14w 24,63 5,92 74,55 94,08 66,51 55,56 3,21 1,59 
16w 17,56 3,51 82,40 96,22 18,80 75,36 0,71 0,74 
18w 28,75 2,58 70,96 96,97 57,10 87,50 0,63 0,77 
18w 16,75 12,17 82,09 85,67 55,32 86,24 3,55 0,78 
19w 5,05 3,69 94,95 96,31 27,24 0,00 3,75 3,79 
19w 30,89 29,15 69,11 70,72 87,15 27,17 0,97 0,90 
20w 43,78 30,27 56,17 69,58 62,07 67,07 0,78 0,61 
20w 18,53 15,06 81,47 84,71 59,38 62,76 1,18 0,14 
 
 
 
The statistical analysis (Figure 10, green box) was performed by comparing the 
values from control xenografts with values from the DBP (MBP) exposed xenografts for 
each analysed group (% OCT3/4+ germ cells; % MAGE-A4+ germ cells; % proliferative 
OCT3/4+ germ cells; % proliferative MAGE-A4+ germ cells). 
Germ cell differentiation in human fetal testis xenografts was assessed by using a 
germ cell pluripotency marker (OCT3/4) and a differentiated germ cell marker (MAGE-
A4) (Figure 11). Human fetal testis xenografts exposed to DBP (or its active metabolite 
MBP) showed a decline in the percentage of OCT3/4+ germ cells of more than 10% 
(paired t-test, t=3,25, df=7, p=0,014) (Figure 12, A). In contrast, when comparing the 
percentage of MAGE-A4+ germ cells, DBP(MBP) treated xenografts show an increase of 
10% above control xenografts (paired t-test, t=3,14, df= 7, p=0,016) (Figure 12, B).  
The proliferation of undifferentiated (OCT3/4+) and differentiated (MAGE-A4+) 
germ cells was measured using a proliferation cell marker, Ki67, which is non-specific 
for germ cells (Figure 11). DBP(MBP) xenografts, when compared to control 
xenografts, showed no difference in the percentage of proliferating OCT3/4+ germ 
cells, which was ~60% (paired t-test, t=0,27, df=7, p=0,795) (Figure 12, C). The 
percentage of MAGE-A4+ germ cells also registered no difference between control and 
DBP(MBP) xenografts, which was ~2% (paired t-test, t=1,84, df=7, p=0,108) (Figure 12 
D). 
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Vehicle 
Control 
 
 
   
DBP 
(MBP) 
 
  
 
Figure 11. Photographs of vehicle control and DBP( MBP) exposed second trimester human fetal 
testis xenografts after the immunofluorescence protocol for OCT3/4 (red; square labelled arrow - 
undifferentiated germ cell marker), MAGE-A4 (blue; star - differentiated germ cell marker) and Ki67 
(green; circle labelled arrow - proliferating cell marker, and note that it co-stains with OCT3/4). A, C are 
confocal images of the testis section that result from overlapped individual tiles. B, D are confocal 
scanned individual tiles used to count germ cells within a clearly defined seminiferous cord and to assess 
their proliferation. Partial germ cells were counted only if they were on the left or bottom limit of the 
tile. Germ cells stained positive for the combinations OCT3/4/MAGE-A4, MAGE-A4/KI67 and 
OCT3/4/MAGE-A4/Ki67 are not shown. Scale bar (A, C) = 500µm; (B, D) = 50µm. 
 
 
 
 
 
B A 
C D 
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Figure 12. Quantification of germ cell differentiation (A,B) and proliferation (C,D) in control (n = 8) 
and DBP(MBP)-exposed (n = 8) second trimester human fetal testis xenografts. 500mg/kg/day of DBP, 
MBP or vehicle (control) were administered to host male nude mice for a period of 21 days, starting 7 
days after xenografting 4-6 human fetal testis pieces under the back skin. Control values include age-
matched control, pre-graft control and vehicle control samples. DBP values include DBP or MBP exposed 
samples. OCT3/4 is a marker for undifferentiated germ cells, MAGE-A4 is a marker for differentiated 
germ cells and proliferation was assessed using the marker Ki67 (unspecific for germ cell). *p < 0,05, in 
comparison with respective control value.; GC, germ cell. 
 
 
 
 
 
 
 
C     % Proliferative OCT3/4+ GC D      % Proliferative MAGE-A4+ GC 
A                % OCT3/4+ GC B                 % MAGE-A4+ GC 
25 
 
The effect of paracetamol and indomethacin on germ cell number 
in e21.5 rat fetal testes 
Germ cell counts were carried out using a stereology method, which calculates the 
germ cell composition of a three-dimensional tissue (as the fetal testis) by counts 
performed in two-dimensional sections from that tissue. In e21.5 rat fetal testis, germ 
cells immunostained with the marker VASA were the only cells considered for counting 
(Figure 13, A-D). The germ cell absolute nuclear volume and the germ cell mean 
nuclear volume were used to calculate the total number of germ cells (in millions) 
present in each testis. After determining the germ cell numbers (in millions) for 
control, paracetamol and indomethacin exposed fetal testes, comparisons among the 
three groups were conducted using one-way ANOVA and a Bonferroni’s  ultiple 
Comparison. All e21.5 rat testis values (millions) can be found at Appendix. 
The number of germ cells in e21.5 testes from indomethacin-exposed fetuses was 
decreased when compared to controls (p<0,05). However, germ cell numbers in e21.5 
testes from paracetamol-exposed fetuses were unaffected, comparing with control 
(p>0,05) or the indomethacin exposed group (p>0,05), although there was a downward 
trend (Figure 13, E). 
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e21.5 
Control 
  
   
e21.5 
Indomethacin 
 
  
   
 
Figure 13. Effect of maternal treatment with paracetamol (350mg/kg/day from e15.5–e20.5) or 
indomethacin (1mg/kg or 0.8mg/kg from e15.5 – e18.5) on germ cell number in rat fetal e21.5 testes. 
Germ cells were immunostained for VASA (brown colour, highlighted with black arrows) and stereology 
used to count the number (millions) of germ cells in control samples (A, B) and in those from 
indomethacin (or paracetamol)-exposed fetuses (C, D). Scale bar (A, B) = 200µm; (C, D) = 50µm. Values 
for control (n = 12), paracetamol (n = 9) and indomethacin (n = 14) exposed fetal testes were compared 
using a one-way ANOVA (E). e, embryonic day; GC, germ cell. *** p<0.001, in comparison with control. 
 
*** 
B A 
C D 
E 
27 
 
The effect of fetal exposure to indomethacin on germ cell number 
in pnd25 rat testes 
To assess if fetal exposure to indomethacin still affected germ cell number after 
the termination of treatment, germ cells were counted using stereology (as for e21.5 
rat fetal testis) in testes from control and indomethacin exposed rats at pnd25. Germ 
cells were immunostained for VASA and separated into three classes that follow the 
temporal progression of spermatogenesis: spermatogonia, early spermatocytes and 
pachytene spermatocytes (Figure 14, A-D). Germ cell absolute and mean nuclear 
volume was calculated for each class of germ cells and germ cell number (millions) was 
then calculated. Total germ cell number (millions) for each sample was also recorded 
by adding all three germ cell class numbers for that sample. All pnd25 rat testis values 
(millions) can be found in Appendix. A Student’s unpaired t-test was used to compare 
the numbers for the different germ cell classes and the total germ cell numbers. 
Spermatogonial numbers (millions) were more than double in pnd25 testes from 
indomethacin-exposed rats, when compared to pnd25 controls (t=3,48; df=6; p=0,013) 
(Figure 15, A). Early and pachytene spermatocyte numbers (millions) were also 
increased, but this did not reach statistical significance (Early spermatocytes: t=1,69; 
df=6; p=0,142; Pachytene spermatocytes: t=0,58; d=6; p=0,583) (Figure 15, B, C). When 
the germ cell data were added together, the total germ cell number was significantly 
increased in indomethacin exposed animals, compared to controls (t=2,66; df=6; 
p=0,037) (Figure 15, D). 
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pnd25 
Indomethacin 
 
  
 
 
Figure 14. Images of control and indomethacin exposed (1mg/kg or 0.8mg/kg from e15.5 – e18.5) 
rat pnd25 testis sections. Germ cells were immunostained for VASA and stereology was used to assess 
the number (millions) of spermatogonia (square labelled arrow), early spermatocytes (circle labelled 
arrow), pachytene spermatocytes (star) and total germ cell number (millions) in control samples (A, B) 
and indomethacin exposed samples (C, D). Scale bar (A, C) = 500µm; (B, D) = 50µm. pnd, postnatal day. 
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Figure 15. Effect of prostaglandin-inhibitor indomethacin (1mg/kg or 0.8mg/kg from e15.5 – e18.5) 
on germ cell number of rat pnd25 testis after termination of the treatment. Germ cells were separated 
in three classes that follow the temporal progression of spermatogenesis: spermatogonia, early 
spermatocytes and pachytene spermatocytes. The total germ cell number for a sample was also 
assessed by adding the values of all classes for that sample. Values for control (n = 4) and indomethacin 
(n = 4) exposed pnd25 testis were compared using a Student’s unpaired t-test (A, D). GC, germ cell. 
*p<0.05, in comparison with respective control value. 
 
 
 
 
 
 
 
 
 
A B 
C D 
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Discussion 
 
DBP effects on male human fetal germ cell differentiation and 
proliferation 
This study focused on the impact that environmental chemical exposure (DBP and 
MBP) has on human germ cell development during fetal life. It was performed to 
assess whether DBP exposure affects male human fetal germ cell differentiation and 
proliferation in a xenograft model (small pieces of human testis xenografted under the 
back skin of castrated adult male nude mice, to which the treatments were given). The 
results show that the percentage of OCT3/4+ (undifferentiated) germ cells is lower in 
human fetal xenografts exposed to DBP (or its active metabolite MBP). 
Correspondingly, the percentage of MAGE-A4+ (differentiated) germ cells was 
increased in DBP-exposed xenografts. Nevertheless, both types of germ cells 
maintained control levels of germ cell proliferation in DBP-exposed samples. Germ 
cells switch the expression of OCT3/4 to MAGE-A4 when they mature (differentiate), 
which coincides with reduction/loss of proliferative activity, reassuring that the 
xenograft model is recapitulating the normal development of male human fetal germ 
cells. 
The reduction in undifferentiated germ cells in DBP-exposed xenografts could be 
explained either by selective death of these cells or an increase in their differentiation. 
To distinguish between these hypotheses, one would have to count all germ cells in 
the testis, which is impossible since the model uses fetal testis xenografts which 
represent only small component parts of the overall fetal testis. From analysis of the 
photographs of the human xenografts, selective death of the undifferentiated germ 
cells seems to be more likely. If indiscriminate apoptosis of germ cells had occurred, 
the proportion of undifferentiated (OCT3/4+) and differentiated (MAGE-A4+) germ cells 
would have remained the same for control and DBP-exposed male human fetal testis 
xenografts. However, my results show that these proportions changed after exposure 
to DBP, with a relative increase in the proportion of differentiated germ cells. 
Therefore, it is plausible that there could have been selective apoptosis of 
undifferentiated germ cells. This would agree with previous reports in the mouse, in 
which in vitro exposure of fetal testis to phthalates induced apoptosis of the germ cell 
lineage during fetal and postnatal life (Lehraiki et al., 2009). Another study in the rat 
showed that in utero exposure to DBP differentially reduced the numbers of OCT3/4+ 
fetal germ cells (Jobling et al., 2011). Moreover, Lambrot et al. (2009) also obtained a 
similar result for in vitro cultures of human fetal testis pieces, where phthalate 
exposure induced a higher rate of germ cell apoptosis, thus reducing the germ cell 
number, with no alteration of proliferation. Additionally, Muczynski et al. (2012) 
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recently reported similar results for in vitro exposure of human fetal testis cultures and 
in utero exposure of mouse fetal testis to MEHP (the monoester metabolite that 
results from the metabolization of DEHP, the most widely used phthalate), both 
resulting in an increased apoptosis of developing germ cells. In all of these in vitro 
studies, the authors did not investigate if the increased apoptosis applied more to 
undifferentiated rather than to differentiated germ cells. 
Hrabalkova (2011) conducted preliminary studies on human fetal testis xenografts 
from DBP-exposed (or its active metabolite MBP) nude mice and also reported a 
difference in proportions of undifferentiated and differentiated germ cells between 
control and DBP exposed xenografts, which the present studies confirm. The 
xenografting technique used in both studies was developed by Mitchell et al. (2010) 
and the xenografts show normal structure, function and development, which 
represent a comparable in vivo ex situ model of normal germ cell development. The 
findings that this model provided could be important for future assessments of 
exposure to environmental chemicals that affect the development of the human male 
gonad, since the results are novel. 
 
 
 
 
Indomethacin effects on male rat fetal germ cell number  
This study also focused on how in utero exposure to paracetamol and 
indomethacin affects male germ cell number during fetal and postnatal life in rats. This 
was performed by analysing rat e21.5 and pnd25 testes, which showed the effects of 
paracetamol/indomethacin exposure during the masculinization programming window 
in the rat. These medicines are nonsteroidal anti-inflammatory drugs that inhibit 
prostaglandin production or action. Hrabalkova (2011) reported in preliminary studies 
that fetal exposure of rats to paracetamol resulted in a decreased number of germ 
cells at the later stage of fetal development (e21.5). Indomethacin was used to further 
evaluate this finding, since it is a more unequivocal prostaglandin inhibitor, and, 
indeed, e21.5 fetal testes from indomethacin-exposed pregnant rats showed a 
reduction in germ cell number when compared to control fetal testes. However, fetal 
testes from rats exposed to paracetamol only showed a small trend towards a 
decreased number of germ cell, without reaching significance. This might be explained 
by the different methods used to count germ cells compared with Hrabalkova (2011), 
as stereology provides a more accurate and unbiased means of quantifying the cellular 
composition of the whole testis. It is still unknown if the germ cell number decrease in 
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rat e21.5 testes after indomethacin exposure is due to apoptosis. However, an 
increase of the differentiation rate of fetal germ cells exposed to indomethacin, 
therefore stopping proliferation at an abnormally early age, could be suggested. 
Nevertheless, a recent in vitro study on human fetal oocytes reported increased 
apoptosis of organ cultures exposed to dexamethasone, a synthetic glucocorticoid and 
a known inflammation modulator (Poulain et al., 2012). Duffy et al. (2010) reported 
that monkey and mouse adult oocytes express functional prostaglandin receptors. A 
COX-2 inhibitor has been shown to directly influence oocyte nuclear maturation and 
reduced the in vitro fertilization rate, blocking several steps in female reproduction 
(Duffy & VandeVoot, 2011). Unpublished preliminary results by Afshan Dean have 
shown that COX-2 and prostaglandin receptors expression could also be found in male 
fetal germ cells in the rat. A recent paper also reported that juvenile mouse Sertoli cell 
lines exposed in vitro to environmental chemicals showed prostaglandin synthesis 
inhibition (Kristensen et al., 2011b). Moreover, administration of COX inhibitors results 
in testicular damage by inducing germ cell apoptosis in postnatal mice (Kubota et al., 
2011).  Although information about the importance of prostaglandins during testis 
development is still scarce, these findings altogether suggest that the fetal germ cell 
line, at least in mammals, needs prostaglandins to assure its normal development and 
maintain fertility. 
On the other hand, this study also analysed the effect of in utero indomethacin 
exposure on germ cell numbers of rat pnd25 testis. This is novel as studying rat pnd25 
testis helps to understand if in utero exposure to a prostaglandin-inhibitor may cause 
permanent consequences, which has not been addressed yet. Because 
spermatogenesis is occurring during this postnatal stage, germ cells were separated 
into categories that follow the temporal progression of germ cell development into 
spermatozoa: spermatogonia, early spermatocytes and pachytene spermatocytes. The 
total germ cell number was also compared between pnd25 testes of vehicle-exposed 
controls and those exposed in utero to indomethacin. Spermatogonial and total germ 
cell numbers showed a significant increase in indomethacin exposed animals, when 
compared to control samples. However, the number of early and pachytene 
spermatocytes only show an upward trend in pnd25 exposed to indomethacin. This 
indicates that there might be slow germ cell replenishment once the exposure to 
indomethacin has stopped (e18.5; 4 days before birth). In adulthood, due to that 
replenishment, germ cell numbers are expected to be normal. The fact that only one 
germ cell type (the more undifferentiated type) shows a significant increase in 
numbers after exposure to indomethacin might be related to its proliferative features, 
since there might be apoptosis of more differentiated germ cells that do not 
proliferate and replenish as quickly as spermatogonia. Therefore, in utero exposure do 
indomethacin seems to trigger apoptosis and a staggered recovery of germ cell 
numbers after birth, as the surviving germ cells (i.e. those that resisted apoptosis) 
could recover and trigger compensation to achieve normal germ cell numbers.  
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To conclude, the results were successful in showing that fetal exposure to 
common environmental chemicals, such as phthalates and the prostaglandin-inhibitor 
indomethacin, can affect fetal germ cell development in human male and the rat, 
addressing this issue for the first time. Ongoing studies are focused on analysing the 
effects of the studied environmental chemicals in females. It is still unclear what effect 
this might have, but if the results mirror those described in this study, exposure to 
environmental chemicals becomes even more problematic. Germ cell number in 
females is fixed prior to birth, so any treatment-induced loss of germ cells that occurs 
at this time cannot be compensated for after birth, unlike in males, and thus could be 
translated into serious fertility lifespan issues. 
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Appendix 
Table I. Germ cell numbers (millions) for e21.5 rat testis exposed to vehicle (control), paracetamol 
or indomethacin treatment, which were used in statistical analysis. 
Treatment 
Control Paracetamol Indomethacin 
0,088592 0,20304 0,160091 
0,265907 0,125893 0,146815 
0,156085 0,14649 0,120480 
0,145142 0,125964 0,134816 
0,176376 0,259754 0,108308 
0,257688 0,229299 0,162236 
0,298938 0,240926 0,162923 
0,358289 0,28822 0,257175 
0,292778 0,295521 0,141253 
0,362374 0,252303 0,136963 
0,373113  0,183987 
0,325335  0,095837 
  0,118078 
  0,112955 
 
 
 
Table II. Spermatogonia, early spermatocytes, pachytene spermatocyes and total germ cell 
numbers (millions) for pnd25 rat testis exposed to vehicle (control) and indomethacin treatment. These 
numbers were then used for statistical analysis.  
Spermatogonia  Early Spermatocytes 
Treatment  Treatment 
Control Indomethacin  Control Indomethacin 
29,10129 47,49326  105,846 189,9936 
36,20188 61,28696  115,3677 164,1512 
21,29265 87,92276  134,8296 106,3772 
44,965245 77,93825  148,94257 210,2121 
     
     
Pachytene Spermatocytes  Total Germ Cells 
Treatment  Treatment 
Control Indomethacin  Control Indomethacin 
38,94679 28,0884  173,8941 265,5753 
49,8942 29,23583  201,4638 254,674 
39,08737 44,26174  195,2096 238,5617 
26,020922 85,46898  219,93 373,6194 
 
